AIM · Categories · Form 4

AIM - SEC Form 4 insider transactions

AIM ImmunoTech Inc. (AIM) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for AIM

• 85d
  CEO & President Equels Thomas K converted options into 25,000 shares, increasing direct ownership by 64% to 63,922 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 85d
  Director Chemerow David I. converted options into 25,000 shares, increasing direct ownership by 727% to 28,441 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 91d
  SEC Form 4 filed by AIM ImmunoTech Inc.

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 91d
  SEC Form 4 filed by AIM ImmunoTech Inc.

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 123d
  Director Chemerow David I. was granted 2,800 shares (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 323d
  SEC Form 4 filed by Director Kellner Ted D

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 448d
  Director Mitchell William M was granted 44,899 shares, increasing direct ownership by 16% to 324,872 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 448d
  Director Bryan Nancy was granted 44,899 shares, increasing direct ownership by 18% to 291,882 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 448d
  Director Chemerow David I. was granted 44,899 shares, increasing direct ownership by 233% to 64,189 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 462d
  Director Chemerow David I. was granted 19,290 shares (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 462d
  Director Mitchell William M was granted 38,580 shares, increasing direct ownership by 16% to 279,973 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 462d
  Director Bryan Nancy was granted 38,580 shares, increasing direct ownership by 19% to 246,983 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 474d
  Amendment: Director Mitchell William M was granted 25,797 shares, increasing direct ownership by 15% to 198,063 units (SEC Form 4)

  4/A - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 474d
  Amendment: Director Mitchell William M was granted 27,412 shares, increasing direct ownership by 19% to 172,266 units (SEC Form 4)

  4/A - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 474d
  Amendment: Director Mitchell William M was granted 43,330 shares, increasing direct ownership by 22% to 241,393 units (SEC Form 4)

  4/A - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 475d
  Director Mitchell William M gave a grant of 43,330 shares, decreasing direct ownership by 15% to 241,393 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 475d
  Director Bryan Nancy was granted 43,330 shares, increasing direct ownership by 26% to 208,403 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 491d
  Director Bryan Nancy was granted 25,797 shares, increasing direct ownership by 19% to 165,073 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 491d
  Director Mitchell William M gave a grant of 25,797 shares, decreasing direct ownership by 12% to 198,063 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 508d
  Director Mitchell William M gave a grant of 27,412 shares, decreasing direct ownership by 14% to 172,226 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 508d
  Director Bryan Nancy was granted 27,412 shares, increasing direct ownership by 25% to 139,276 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 522d
  Director Bryan Nancy was granted 26,305 shares, increasing direct ownership by 31% to 111,864 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 522d
  Director Mitchell William M was granted 26,305 shares, increasing direct ownership by 22% to 144,854 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 522d
  Director Appelrouth Stewart was granted 8,768 shares, increasing direct ownership by 2% to 388,729 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 536d
  Director Mitchell William M sold $884 worth of shares (4,580 units at $0.19), decreasing direct ownership by 4% to 118,549 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 539d
  Director Mitchell William M was granted 24,452 shares, increasing direct ownership by 25% to 123,803 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 539d
  Director Bryan Nancy was granted 24,452 shares, increasing direct ownership by 40% to 85,559 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 539d
  Director Appelrouth Stewart was granted 24,452 shares, increasing direct ownership by 7% to 379,961 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 552d
  Director Mitchell William M was granted 22,645 shares, increasing direct ownership by 30% to 99,351 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 552d
  Director Appelrouth Stewart was granted 22,645 shares, increasing direct ownership by 7% to 344,397 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 552d
  Director Bryan Nancy was granted 22,645 shares, increasing direct ownership by 59% to 61,107 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 635d
  CEO & President Equels Thomas K was granted 312,500 shares, increasing direct ownership by 27% to 1,468,042 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 665d
  COO, Secretary, Gen. Counsel Rodino Peter W Iii was granted 188,679 shares, increasing direct ownership by 89% to 401,262 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 665d
  CEO & President Equels Thomas K was granted 377,358 shares, increasing direct ownership by 48% to 1,155,542 units (SEC Form 4)

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 804d
  SEC Form 4 filed by Rodino Peter W Iii

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 804d
  SEC Form 4 filed by Equels Thomas K

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 1019d
  SEC Form 4: Equels Thomas K bought $5,501 worth of shares (8,222 units at $0.67), increasing direct ownership by 1% to 584,160 units

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 1020d
  SEC Form 4: Equels Thomas K bought $10,000 worth of shares (14,993 units at $0.67), increasing direct ownership by 3% to 575,938 units

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 1057d
  SEC Form 4 filed by Equels Thomas K

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 1187d
  SEC Form 4: Appelrouth Stewart disposed of $83,896 worth of shares (68,208 units at $1.23), decreasing direct ownership by 31% to 148,855 units

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 1252d
  SEC Form 4: Rodino Peter W Iii bought $25,000 worth of shares (80,646 units at $0.31), increasing direct ownership by 128% to 143,839 units

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 1252d
  SEC Form 4: Equels Thomas K bought $50,000 worth of shares (161,291 units at $0.31), increasing direct ownership by 42% to 543,995 units

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 1252d
  SEC Form 4: Appelrouth Stewart bought $25,000 worth of shares (80,646 units at $0.31), increasing direct ownership by 59% to 217,063 units

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 1253d
  SEC Form 4 filed by Lintal Ellen M

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 1285d
  SEC Form 4 filed by Equels Thomas K

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 1285d
  SEC Form 4 filed by Appelrouth Stewart

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 1285d
  SEC Form 4 filed by Rodino Peter W Iii

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 1285d
  SEC Form 4 filed by Mitchell William M

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 1422d
  SEC Form 4: Equels Thomas K was granted 32,895 shares, increasing direct ownership by 9% to 382,704 units

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 1504d
  SEC Form 4: Appelrouth Stewart was granted 24,500 shares, increasing direct ownership by 22% to 136,417 units

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 1505d
  SEC Form 4: Rodino Peter W Iii was granted 4,902 shares, increasing direct ownership by 8% to 63,193 units

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 1505d
  SEC Form 4: Equels Thomas K was granted 49,020 shares, increasing direct ownership by 16% to 349,809 units

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 1558d
  SEC Form 4 filed by Rodino Peter W Iii

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 1558d
  SEC Form 4 filed by Mitchell William M

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 1558d
  SEC Form 4 filed by Lintal Ellen M

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 1558d
  SEC Form 4 filed by Equels Thomas K

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 1558d
  SEC Form 4 filed by Appelrouth Stewart

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 1639d
  SEC Form 4: Equels Thomas K was granted 21,552 shares (Amendment)

  4/A - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 1639d
  SEC Form 4: Equels Thomas K was granted 21,552 shares, increasing direct ownership by 8% to 300,789 units

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
• 1642d
  SEC Form 4: Equels Thomas K was granted 11,811 shares, increasing direct ownership by 4% to 279,237 units

  4 - AIM ImmunoTech Inc. (0000946644) (Issuer)

Other AIM categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends